Your browser doesn't support javascript.
loading
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).
Banys-Paluchowski, Maggie; Kühn, Thorsten; Masannat, Yazan; Rubio, Isabel; de Boniface, Jana; Ditsch, Nina; Karadeniz Cakmak, Güldeniz; Karakatsanis, Andreas; Dave, Rajiv; Hahn, Markus; Potter, Shelley; Kothari, Ashutosh; Gentilini, Oreste Davide; Gulluoglu, Bahadir M; Lux, Michael Patrick; Smidt, Marjolein; Weber, Walter Paul; Aktas Sezen, Bilge; Krawczyk, Natalia; Hartmann, Steffi; Di Micco, Rosa; Nietz, Sarah; Malherbe, Francois; Cabioglu, Neslihan; Canturk, Nuh Zafer; Gasparri, Maria Luisa; Murawa, Dawid; Harvey, James.
  • Banys-Paluchowski M; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany.
  • Kühn T; Department of Gynecology and Obstetrics, Die Filderklinik, 70794 Filderstadt, Germany.
  • Masannat Y; Aberdeen Breast Unit, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK.
  • Rubio I; Breast Surgical Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.
  • de Boniface J; Department of Molecular Medicine and Surgery, Karolinska Institutet, 17177 Stockholm, Sweden.
  • Ditsch N; Department of Surgery, Capio St. Göran's Hospital, 11219 Stockholm, Sweden.
  • Karadeniz Cakmak G; Breast Cancer Center, University Hospital Augsburg, 86156 Augsburg, Germany.
  • Karakatsanis A; Breast and Endocrine Unit, General Surgery Department, Zonguldak BEUN The School of Medicine, Kozlu/Zonguldak 67600, Turkey.
  • Dave R; Department for Surgical Sciences, Faculty of Pharmacy and Medicine, Uppsala University, 75236 Uppsala, Sweden.
  • Hahn M; Section for Breast Surgery, Department of Surgery, Uppsala University Hospital, 75236 Uppsala, Sweden.
  • Potter S; Nightingale & Genesis Breast Cancer Prevention Centre, Manchester University NHS Foundation Trust, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
  • Kothari A; Department for Women's Health, University of Tübingen, 72076 Tübingen, Germany.
  • Gentilini OD; Bristol Medical School (THS), Bristol Population Health Science Institute, Bristol BS8 1QU, UK.
  • Gulluoglu BM; Guy's & St Thomas NHS Foundation Trust, Kings College, London SE1 9RT, UK.
  • Lux MP; Department of Breast Surgery, San Raffaele University and Research Hospital, 20132 Milan, Italy.
  • Smidt M; Department of Surgery, Breast Surgery Unit, Marmara University School of Medicine and SENATURK Turkish Academy of Senology, Istanbul 34854, Turkey.
  • Weber WP; Department of Gynecology and Obstetrics, St. Louise Frauen-und Kinderklinik, 33098 Paderborn, Germany.
  • Aktas Sezen B; Department of Surgical Oncology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
  • Krawczyk N; Division of Breast Surgery, Department of Surgery, Basel University Hospital, 4031 Basel, Switzerland.
  • Hartmann S; European Breast Cancer Research Association of Surgical Trialists (EUBREAST), 73730 Esslingen, Germany.
  • Di Micco R; Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
  • Nietz S; Department of Gynecology and Obstetrics, University Hospital Rostock, 18059 Rostock, Germany.
  • Malherbe F; Department of Breast Surgery, San Raffaele University and Research Hospital, 20132 Milan, Italy.
  • Cabioglu N; Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.
  • Canturk NZ; Breast and Endocrine Surgery Unit, Groote Schuur Hospital, University of Cape Town, Cape Town 7935, South Africa.
  • Gasparri ML; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul 34093, Turkey.
  • Murawa D; Department of General Surgery, Kocaeli University School of Medicine, Kocaeli 41001, Turkey.
  • Harvey J; Department of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, 6900 Lugano, Switzerland.
Cancers (Basel) ; 15(4)2023 Feb 12.
Article en En | MEDLINE | ID: mdl-36831516
BACKGROUND: Surgical excision of a non-palpable breast lesion requires a localization step. Among available techniques, wire-guided localization (WGL) is most commonly used. Other techniques (radioactive, magnetic, radar or radiofrequency-based, and intraoperative ultrasound) have been developed in the last two decades with the aim of improving outcomes and logistics. METHODS: We performed a systematic review on localization techniques for non-palpable breast cancer. RESULTS: For most techniques, oncological outcomes such as lesion identification and clear margin rate seem either comparable with or better than for WGL, but evidence is limited to small cohort studies for some of the devices. Intraoperative ultrasound is associated with significantly higher negative margin rates in meta-analyses of randomized clinical trials (RCTs). Radioactive techniques were studied in several RCTs and are non-inferior to WGL. Smaller studies show higher patient preference towards wire-free localization, but little is known about surgeons' and radiologists' attitudes towards these techniques. CONCLUSIONS: Large studies with an additional focus on patient, surgeon, and radiologist preference are necessary. This review aims to present the rationale for the MELODY (NCT05559411) study and to enable standardization of outcome measures for future studies.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article